Post by Alira Health

The 2025 Global Biosimilars Report is here! This updated edition of our foundational 2024 analysis uses refreshed 2025 data and forecasts to provide a consistent, year-over-year view of global biosimilar activity, from launches to market access trends. Start reading to explore how the biosimilars market continues to evolve worldwide: https://lnkd.in/entwxb_N   Questions about this market? Connect with the authors and Chairs of our Biosimilars Center of Excellence: 🔵 Christian Hughes, Principal, Transaction Advisory Services 🔵 Alexandra Essler (Wollersheim), Partner, Transaction Advisory Services 🔵 Joris Pezzini, Executive Vice President of Biopharma